The update comes after Q&M placed Dr Ong on a leave of absence in June 2024 after the latter acquired an indirect interest in the assets of a supplier of Acumen.
Q&M Dental Group, on March 22, announced that it entered into a settlement agreement with Dr Ong Siew Hwa, the CEO of Acumen Diagnostics. Acumen is a subsidiary of Mainboard-listed Q&M Dental Group (SGX:QC7
) and an associated company of Catalist-listed Aoxin Q&M (SGX:1D4) Dental Group.
While the terms of the agreement remain confidential, the parties have “agreed to a full and final settlement of all disputes, with no admission as to liability by any party”, says Q&M in its March 22 statement.
